Updated Oct 9, 2026 · 05:00 UTC
ALNYAlnylam Pharmaceuticals, Inc.
Health Care · United States · XNAS · pharmaceutical preparations
$224.63+0.05%last session · market closed
Market cap
$30.06b
real-world
Tokenized
$964
<0.001% of the asset
Avg token price
$224.36
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
ALNY · Price
Apr 28, 2025low $205.46 · high $488.42 · now $222.03Oct 8, 2026
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 29
estimated date · Sep 2026 quarter · EPS forecast $1.68 (9 analysts)
Last earnings, Jul 30
$1.21 EPS
−16.0% vs $1.44 forecast · Jun 2026 quarter
Real market
Alnylam Pharmaceuticals, Inc.
Last close
$224.41
Oct 7
Traded on Oct 7
$240.5m
Price now
$224.63
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions
1 token from 1 issuer
wALNYxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
In DeFi
Pools and lending markets that hold these tokens
None found
Business Quarter to Jun 2026 · SEC EDGAR
Revenue
$1.29b
Net income
$164.5m
13% margin
Cash
$1.71b
Quarterly
RevenueNet income